202 related articles for article (PubMed ID: 10685634)
1. Histopathologic analysis of chromosome aneuploidy in ductal carcinoma in situ.
Visscher D; Jimenez RE; Grayson M; Mendelin J; Wallis T
Hum Pathol; 2000 Feb; 31(2):201-7. PubMed ID: 10685634
[TBL] [Abstract][Full Text] [Related]
2. Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization.
Mendelin J; Grayson M; Wallis T; Visscher DW
Lab Invest; 1999 Apr; 79(4):387-93. PubMed ID: 10211991
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics.
Visscher DW; Wallis TL; Crissman JD
Cancer; 1996 Jan; 77(2):315-20. PubMed ID: 8625240
[TBL] [Abstract][Full Text] [Related]
4. Abnormal chromosome 8 copy number in cytological smears from breast carcinomas detected by means of fluorescence in situ hybridization (FISH).
Bofin AM; Ytterhus B; Fjøsne HE; Hagmar BM
Cytopathology; 2003 Feb; 14(1):5-11. PubMed ID: 12588304
[TBL] [Abstract][Full Text] [Related]
5. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.
Murphy DS; Hoare SF; Going JJ; Mallon EE; George WD; Kaye SB; Brown R; Black DM; Keith WN
J Natl Cancer Inst; 1995 Nov; 87(22):1694-704. PubMed ID: 7473818
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of numerical abnormalities of chromosomes 1 and 17 in proliferative epithelial breast lesions using fluorescence in situ hybridization.
Marinho AF; Botelho M; Schmitt FC
Pathol Res Pract; 2000; 196(4):227-33. PubMed ID: 10782466
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of ductal carcinoma in situ (DCIS) and intraductal papilloma using fluorescence in situ hybridization (FISH) analysis.
Komoike Y; Motomura K; Inaji H; Koyama H
Breast Cancer; 2000; 7(4):332-6. PubMed ID: 11114860
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 1 aneusomy, identified by interphase cytogenetics, in mammographically detected ductal carcinoma in situ of the breast.
Harrison M; Magee HM; O'Loughlin J; Gorey TF; Dervan PA
J Pathol; 1995 Mar; 175(3):303-9. PubMed ID: 7745499
[TBL] [Abstract][Full Text] [Related]
9. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.
Jimenez RE; Wallis T; Tabasczka P; Visscher DW
Mod Pathol; 2000 Jan; 13(1):37-45. PubMed ID: 10658908
[TBL] [Abstract][Full Text] [Related]
10. Alteration of numerical chromosomal aberrations during progression of colorectal tumors revealed by a combined fluorescence in situ hybridization and DNA ploidy analysis of intratumoral heterogeneity.
Katsura K; Sugihara H; Nakai S; Fujita S
Cancer Genet Cytogenet; 1996 Sep; 90(2):146-53. PubMed ID: 8830725
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence in situ hybridization assessment of chromosome 8 copy number in stage I and stage II infiltrating ductal carcinoma of the breast.
Afify A; Mark HF
Cancer Genet Cytogenet; 1997 Sep; 97(2):101-5. PubMed ID: 9283590
[TBL] [Abstract][Full Text] [Related]
12. Karyotypic heterogeneity and its relation to labeling index in interphase breast tumor cells.
Balazs M; Matsumura K; Moore D; Pinkel D; Gray JW; Waldman FM
Cytometry; 1995 May; 20(1):62-73. PubMed ID: 7600900
[TBL] [Abstract][Full Text] [Related]
13. Stage I and stage II infiltrating ductal carcinoma of the breast analyzed for chromosome 8 copy number using fluorescent in situ hybridization.
Mark HF; Taylor W; Afify A; Riera D; Rausch M; Huth A; Gray Y; Santoro K; Bland KI
Pathobiology; 1997; 65(4):184-9. PubMed ID: 9396041
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of chromosome 1 and 8 copy number in invasive ductal breast carcinoma among Iranian women: an interphase FISH analysis.
Behjati F; Atri M; Najmabadi H; Nouri K; Zamani M; Mehdipour P
Pathol Oncol Res; 2005; 11(3):157-63. PubMed ID: 16195769
[TBL] [Abstract][Full Text] [Related]
15. Correlation of HER2 overexpression with gene amplification and its relation to chromosome 17 aneuploidy: a 5-year experience with invasive ductal and lobular carcinomas.
Nassar A; Khoor A; Radhakrishnan R; Radhakrishnan A; Cohen C
Int J Clin Exp Pathol; 2014; 7(9):6254-61. PubMed ID: 25337277
[TBL] [Abstract][Full Text] [Related]
16. Interphase cytogenetic analysis of erbB2 and topoII alpha co-amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinoma in situ.
Murphy DS; McHardy P; Coutts J; Mallon EA; George WD; Kaye SB; Brown R; Keith WN
Int J Cancer; 1995 Feb; 64(1):18-26. PubMed ID: 7665243
[TBL] [Abstract][Full Text] [Related]
17. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.
Fujii H; Szumel R; Marsh C; Zhou W; Gabrielson E
Cancer Res; 1996 Nov; 56(22):5260-5. PubMed ID: 8912866
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal aneuploidy precedes morphological changes and supports multifocality in head and neck lesions.
Ai H; Barrera JE; Meyers AD; Shroyer KR; Varella-Garcia M
Laryngoscope; 2001 Oct; 111(10):1853-8. PubMed ID: 11801957
[TBL] [Abstract][Full Text] [Related]
19. Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH.
Aubele M; Mattis A; Zitzelsberger H; Walch A; Kremer M; Welzl G; Höfler H; Werner M
Int J Cancer; 2000 Jan; 85(1):82-6. PubMed ID: 10585588
[TBL] [Abstract][Full Text] [Related]
20. Aneuploidy of chromosome 8 as detected by interphase fluorescence in situ hybridization is a recurrent finding in primary and metastatic breast cancer.
Roka S; Fiegl M; Zojer N; Filipits M; Schuster R; Steiner B; Jakesz R; Huber H; Drach J
Breast Cancer Res Treat; 1998 Mar; 48(2):125-33. PubMed ID: 9596484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
